The high-affinity choline transporter (CHT1), which is specifically expressed in cholinergic neurons, constitutes a rate-limiting step for acetylcholine synthesis. We have found that the exogenous ubiquitin ligase Nedd4-2 interacts with CHT1 expressed in HEK293 cells decreasing the amount of cell surface CHT1 by approximately 40%, and that small interfering RNA for endogenous Nedd4-2 enhances the choline uptake activity by CHT1 in HEK293 cells. These results indicate that Nedd4-2-mediated ubiquitination regulates the cell surface expression of CHT1 in cultured cells and suggest a possibility that treatments or drugs which inhibit the interaction between CHT1 and Nedd4-2 might be useful for diseases involving decrease in acetylcholine level such as Alzheimer's disease.
In cholinergic neurons, acetylcholine is synthesized from choline and acetyl-CoA by choline acetyltransferase in the cytoplasm and then incorporated into synaptic vesicles by a vesicular acetylcholine transporter (VAChT). Choline is taken up in the presynaptic terminal by the Na + -dependent, hemicholinium-3 (HC-3)-sensitive high-affinity choline transporter (CHT1), which is specifically expressed in cholinergic neurons (8, 11, 16, 24) . Choline uptake by CHT1 is thought to be the rate-limiting step for the synthesis of acetylcholine. CHT1-mediated choline uptake is essential for postnatal viability (6) . CHT1 functions at the cell surface but is predominantly localized in synaptic vesicles in cholinergic neurons and in endosomal compartments in cultured cells, while many other neurotransmitter transporters are predominantly localized at the cell surface in neurons or cultured cells (7, 14, 17, 19) . CHT1 has been reported to be internalized in a clathrin-dependent manner in which a dileucine-like motif present in the carboxyl terminus interacts with adaptor proteins (19) . The exocytosis of synaptic vesicles has been shown to enhance the cell surface expression of CHT1 (7, 14) . It is well known that posttranslational modifications of transmembrane proteins, such as phosphorylation, glycosylation and ubiquitination, regulate their intracellular trafficking. Ubiquitination occurs by the sequential action of three enzymes whose combined actions catalyze the conjugation of ubiquitin to a target protein: a ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2) and a ubiquitin ligase (E3) (21) . E3 interacts with the substrate as well as with E2, and it is the principal determinant of substrate specificity. Only a few ubiquitin E3 ligases, including Nedd4-2, have been characterized. The ubiquitin ligase Nedd4-2 is expressed in various tissues, and particularly highly expressed in brain as well as in liver and kidney (9) . In cultured dorsal root ganglion neurons, Nedd4-2 is shown to be expressed in cytoplasm and plasma membrane (1). Nedd4-2 is also known to regulate cell surface expression and trafficking of neurotransmitter transporters, such as the dopamine transporter (DAT), excitatory amino acid transporter 1 (EAAT1), EAAT2 according to the manufacturer's protocol. All constructs were confirmed by sequencing using an ABI PRISM 3100-Avant Genetic Analyzer (Applied Biosystems, Foster City, CA).
Cell culture. Human embryonic kidney (HEK) 293 cells were cultured in Dulbecco's modified Eagle's medium (Sigma) supplemented with 10% fetal bovine serum (Invitrogen) at 37°C in a 5% CO 2 atmosphere. HEK293 cells that stably expressed hemagglutinin (HA)-CHT1-FLAG (CHT1 fused to HA at the amino terminus and FLAG at the carboxyl terminus) were selected using G418 (Invitrogen). The expression level of Nedd4-2 transfected to HEK293 cells is approximately ten-fold higher than that of endogenous Nedd4-2, as assessed by immunoblot analysis (data not shown).
Immunoprecipitation. HEK293 cells grown in 6-well culture plates were transiently transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. At 48 h after transfection, cells were washed twice with phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 8.1 mM Na 2 HPO 4 (pH 7.4)) and lysed in lysis buffer (25 mM HEPES-KOH (pH 7.6), 100 mM NaCl, 0.5% Triton X-100, 1 mM phenylmethylsulfonyl fluoride (PMSF), and 2 mM EDTA). Cell lysates were incubated with anti-FLAG or anti-Myc antibodies and then with protein G sepharose beads (Protein G Sepharose 4 Fast Flow; GE Healthcare, Buckinghamshire, UK). Sepharose beads were washed with lysis buffer, and bound proteins were then eluted with sodium dodecyl sulfate (SDS) sample buffer (50 mM Tris-HCl (pH 6.8), 10% glycerol, 2% SDS, 6% β-mercaptoethanol, and 0.001% bromophenol blue) and subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) followed by immunoblot analysis. (2, 3, 13, 18, 22) . The sodium-glucose cotransporter 1 (SGLT1), which belongs to the same solute carrier 5 (SLC5) family as CHT1, is also regulated by Nedd4-2 (4). To date, however, no reports are available regarding ubiquitination of CHT1 and its impact on the cell surface expression of CHT1. We report here that CHT1 expressed in HEK293 cells is ubiquitinated by both exogenous and endogenous Nedd4-2 and that this ubiquitination negatively regulates the expression of CHT1 at the cell surface.
MATERIALS AND METHODS

Materials.
Ci/mmol) were purchased from PerkinElmer Life & Analytical Sciences (Boston, MA), the mammalian expression vector pcDNA3.1(+) from Invitrogen (Carlsbad, CA), p3XFLAG-CMV-10 from Sigma-Aldrich (St. Louis, MO), pCMV-Myc from Clontech (Palo Alto, CA), and cDNA for human Nedd4-2 (KIAA0439) from the Kazusa DNA Research Institute (Chiba, Japan), the anti-FLAG (M2) antibody from Sigma-Aldrich, the anti-c-Myc (Myc, 9E10) antibody from Santa Cruz Biotechnology (Santa Cruz, CA), the antiubiquitin (FK2) antibody from Enzo Life Sciences (Farmingdale, NY), the Nedd4-2 (NEDD4L) antibody from Cell Signaling Technology (Danvers, MA), and the anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody from Ambion (Austin, TX). cDNA for the human CHT1 (15, 17) and anti-CHT1 antibody (10, 17) were prepared as described previously.
Construction of mammalian expression vectors.
Human CHT1 cDNA was subcloned into the BamHI/ EcoRI sites of pcDNA3.1(+). The resulting construct was digested with HindIII and EcoRI and cloned into the HindIII/EcoRI sites of the p3XFLAG-CMV-10 vector to generate FLAG-CHT1. A FLAGtagged Nedd4-2 expression vector (FLAG-Nedd4-2) was constructed as follows: the open reading frame of human Nedd4-2 cDNA was amplified using polymerase chain reaction (PCR) using Nedd4-2 cDNA (KIAA0439) as a template and ligated into the HindIII/EcoRI sites of p3XFLAG-CMV-10. The Myctagged Nedd4-2 expression vector (Myc-Nedd4-2) was constructed by ligating FLAG-Nedd4-2 into the BglII/KpnI sites of pCMV-Myc. Site-directed mutagenesis was performed using the QuikChange SiteDirected Mutagenesis kit (Stratagene, La Jolla, CA) acted biotin, cells were washed three times with PBS/Ca-Mg. Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer (10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% TritonX-100, 0.5% sodium deoxycholate, 0.1% SDS, and 1 mM PMSF) at 4°C and centrifuged at 17,000 × g for 15 min. Biotinylated proteins were adsorbed on UltraLink Plus Immobilized Streptavidin Gel (Pierce) by incubation at 4°C on a rotating platform for 1 h. Beads were washed five times with RIPA buffer. Biotinylated proteins were eluted with SDS sample buffer and subjected to SDS-PAGE followed by immunoblot analysis using anti-CHT1 or anti-FLAG antibodies.
RESULTS
CHT1 interacts with Nedd4-2 in HEK293 cells
To examine whether CHT1 interacts with Nedd4-2, FLAG-CHT1 was transiently cotransfected with either Myc-tagged Nedd4-2 (Myc-Nedd4-2) or empty vector into HEK293 cells. Cells were lysed, and Nedd4-2 was immunoprecipitated with the anti-Myc antibody. Immunoprecipitates were subjected to immunoblot analysis using the anti-FLAG antibody. FLAG-CHT1 was detected in the anti-Myc immunoprecipitates, suggesting that Nedd4-2 and CHT1 interact with each other (Fig. 1A , IB: FLAG, lane 2). This was further supported by immunoprecipitation using the anti-FLAG antibody and detection with the anti-Myc antibody (Fig. 1B , IB: Myc, lane 2). No signal was observed when either FLAG-CHT1 or Myc-Nedd4-2 was coexpressed with only the empty vector and then immunoprecipitated with the anti-Myc antibody followed by immunoblot analysis (Fig. 1A, IB: FLAG, lanes 1 and 3, Fig. 1B , IB: Myc, lanes 1 and 3).
Nedd4-2 decreases CHT1 activity
We next examined whether Nedd4-2 influenced the activity of CHT1. HC-3 is a specific membraneimpermeable inhibitor of CHT1, and therefore [ 3 H]HC-3 binding activity represents the expression level of CHT1 on the cell surface. As shown in Fig. 2A, H]choline uptake was determined by subtracting the uptake in the presence of 1 μM HC-3 from the uptake in its absence. The uptake assay was performed in triplicate and repeated in at least three independent experiments.
RNA interference. Small interfering RNA (siRNA) sequences corresponding to human Nedd4-2 nucleotides 729-749 of the coding sequence were selected as described previously (12) . The sense sequences of Nedd4-2 siRNA 729-749 were 5'-AAGUGGA CAAUUUAGGCCGAA-3'. siRNA expression construct was generated by cloning pairs of annealed DNA oligonucleotides into the BamHI/HindIII sites of pSilencer 2.1-U6 neo (Ambion), developed for the construction of vector-based siRNA, according to the manufacturer's protocol. The pSilencer2.1-U6 neo Negative Control (Ambion) was used as negative control siRNA. siRNA expression construct was confirmed by sequencing as described above. The expression level of Nedd4-2 in the presence and absence of siRNA was evaluated by immunoblot analysis, where the expression level of GAPDH was used as control.
Cell surface biotinylation. The expression of CHT1 on the cell surface was directly identified by the cell surface biotinylation assay, which was performed as described previously (17) . Briefly, cells grown in 6-well culture plates were transiently transfected using Lipofectamine 2000. At 48 h after transfection, cells were washed twice with PBS/Ca-Mg (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH 2 PO 4 , 8.1 mM Na 2 HPO 4 , 0.1 mM CaCl 2 , and 1 mM MgCl 2 (pH 7.4)) and then treated with 1.0 mg/mL sulfo-NHS-SS-biotin (Pierce, Rockford, IL) in PBS/Ca-Mg for 1 h at 4°C to biotinylate cell surface proteins. To remove unre-sion of FLAG-Nedd4-2, but not the inactive C962S mutant, led to a decrease in the density of a band with an apparent MW of 60 kDa and a concomitant increase in a band with apparent MW of more than 250 kDa. The 60 kDa band and the > 250 kDa band were considered to be CHT1 molecules without and with ubiquitin bound, respectively. In fact, the > 250 kDa band was labeled by the anti-ubiquitin antibody (Fig. 3B) . These results indicate that CHT1 present at the cell surface can be ubiquitinated.
The role of intracellular lysine residues in CHT1
Intracellular lysine residues in membrane proteins are known to be targets of ubiquitination; therefore, we attempted to identify which of the 13 intracellular lysine residues of CHT1 were involved in the regulation of its activity. In preliminary experiments, we constructed 13 mutants that had a single lysine residue replaced with arginine and found that 2 mutants, K104R and K124R had lower choline uptake activities than wild type (WT), whereas other mutants had similar or slightly higher activities compared to WT (data not shown (Fig. 2C, Table 1 ). The equilibrium dissociation constant for [ (Fig. 2C, Table 1 ). The maximal velocity of choline uptake (V max ) in cells with coexpression of Nedd4-2 (V max = 95 ± 4 pmol/min/mg protein) was also decreased by 50% as compared the cells without its coexpression (V max = 210 ± 10 pmol/min/mg protein) (Fig. 2D, Table 1 ). The affinity for choline (K m ) was not altered significantly between the cells with coexpression of Nedd4-2 (K m = 1.8 ± 0.2 μM) and those without its coexpression (K m = 2.5 ± 0.5 μM) (Fig. 2D, Table 1 ). These results indicate that the coexpression of Nedd4-2 decreases the level of CHT1 on the cell surface by approximately 50% but does not affect the specific activity of CHT1 on the cell surface. We next examined if the expression level of CHT1 on the cell surface could be affected by endogenous Nedd4-2. For the purpose, an siRNA expression vector for Nedd4-2 was constructed as described in Materials and Methods and transiently transfected into HEK293 cells that stably expressed HA-CHT1-FLAG. As was shown in Fig. 2E , the expression level of Nedd4-2 was markedly decreased by transfection of the siRNA as compared to cells transfected with control siRNA. The transfection of the siRNA was found to cause significant enhancement of both [ 3 H]HC-3-binding and [ 3 H]choline uptake activities compared with control cells that were transiently transfected with control siRNA (Fig. 2F, G) . These results indicate that endogenous Nedd4-2 regulates the cell surface expression of CHT1.
Nedd4-2 enhances the ubiquitination of CHT1 at the cell surface
We attempted to examine whether the ubiquitination of CHT1 by Nedd4-2 occurred at the cell surface. For this purpose, CHT1 and FLAG-Nedd4-2 were transiently coexpressed in HEK293 cells, which were then treated with the membrane-impermeable amine-reactive biotinylation reagent sulfo-NHS-SSbiotin. Biotinylated proteins were solubilized using detergent, isolated using avidin-conjugated beads, and subjected to immunoblot analysis using the anti-CHT1 antibody. As shown in Fig. 3A , the coexpres- 
DISCUSSION
In the present study, we showed that CHT1 expressed in HEK293 cells interacts with the ubiquitin ligase Nedd4-2 when expressed in the same cells and that coexpression of Nedd4-2 decreases the HC-3-binding and choline uptake activities by CHT1, ties of mutants with substitutions of multiple lysine residues and found that higher [ 3 H]HC-3 binding and [ 3 H]choline uptake activities were observed for the mutants with more substitutions at lysine residues, up to ten substitutions (Fig. 4) . This result indicates that at least ten lysine residues may be replaced by arginine residues without loss of CHT1 activity, and those lysine residues may serve as sites of ubiquitination. On the other hand, additional substitutions of K104R and K124R (from 11KR to 13KR in Fig. 4 ) caused marked decrease in both A, CHT1 and FLAG-Nedd4-2 were transiently coexpressed in HEK293 cells. Cells were treated with the membrane-impermeable amine-reactive biotinylation reagent sulfo-NHS-SS-biotin at 4°C for 1 h. Biotinylated proteins were isolated and subjected to immunoblot analysis. The signals corresponding to high-molecular-weight species were increased when CHT1 and FLAG-Nedd4-2 were coexpressed. B, FLAG-CHT1 was transiently expressed in HEK293 cells. Cells were lysed, and proteins were immunoprecipitabled with the anti-FLAG antibody followed by immunoblot analysis using the anti-ubiquitin antibody. understood. The present results show that in addition to these two other proteins, Nedd4-2 is also a negative regulator of the cell surface expression of CHT1. If the interaction of Nedd4-2 with CHT1 could be inhibited, CHT1 activity might be enhanced; such a treatment might be useful for diseases involving cholinergic dysfunction, such as Alzheimer's disease.
To our knowledge, the present results provide the first evidence that Nedd4-2 regulates the activity of CHT1 on the cell surface, most probably by interacting with CHT1.
